The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, P.
Right arrow Articles by Chen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, P.
Right arrow Articles by Chen, T.
The Journal of Immunology, 2006, 177: 4002-4011.
Copyright © 2006 by The American Association of Immunologists, Inc.

Role of N-Acetylglucosamine within Core Lipopolysaccharide of Several Species of Gram-Negative Bacteria in Targeting the DC-SIGN (CD209)1

Pei Zhang*, Scott Snyder{dagger}, Peter Feng{ddagger}, Parastoo Azadi{dagger}, Shusheng Zhang*, Silvia Bulgheresi§, Kenneth E. Sanderson, Johnny He||, John Klena2,# and Tie Chen2,*

* Department of Biomedical Sciences, College of Medicine, University of Illinois at Chicago, Rockford, IL 61107; {dagger} Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602; {ddagger} Division of Microbiological Studies, U.S. Food and Drug Administration, College Park, MD 20740; § Faculty of Life Sciences, Department of Marine Biology, University of Vienna, Vienna, Austria; Salmonella Genetic Stock Centre, Department of Biological Sciences, Alberta, Canada; || Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202; and # School of Biological Sciences, University of Canterbury, Christchurch, New Zealand


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Our recent studies have shown that the dendritic cell-specific ICAM nonintegrin CD209 (DC-SIGN) specifically binds to the core LPS of Escherichia coli K12 (E. coli), promoting bacterial adherence and phagocytosis. In this current study, we attempted to map the sites within the core LPS that are directly involved in LPS-DC-SIGN interaction. We took advantage of four sets of well-defined core LPS mutants, which are derived from E. coli, Salmonella enterica serovar Typhimurium, Neisseria gonorrhoeae, and Haemophilus ducreyi and determined interaction of each of these four sets with DC-SIGN. Our results demonstrated that N-acetylglucosamine (GlcNAc) sugar residues within the core LPS in these bacteria play an essential role in targeting the DC-SIGN receptor. Our results also imply that DC-SIGN is an innate immune receptor and the interaction of bacterial core LPS and DC-SIGN may represent a primeval interaction between Gram-negative bacteria and host phagocytic cells.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Dendritic cells (DCs)3 are professional phagocytic cells that play an essential role in host defense against invading pathogens and help control and maintain innate and adaptive immunity. Microbial pathogens are able to subvert several functions of DCs, such as Ag-presentation, production of different chemokines and cytokines, and phagocytosis (1, 2).

DCs express a C-type lectin called DC-specific ICAM-grabbing nonintegrin (DC-SIGN), CD209, which allows DCs to interact with microorganisms such as Helicobacter pylori, certain strains of Klebsiella pneumoniae, and Mycobacterium tuberculosis (3, 4, 5, 6, 7). DC-SIGN also serves as a receptor for the gp120 Ag of HIV-1 and acts as a carrier for HIV-1 viruses, delivering them to target cells such as CD4 lymphocytes (8, 9, 10). Although the signal transduction pathway by which DC-SIGN mediates the uptake of microorganisms are not yet clear, the ITAM-like motif within the cytoplasmic domain might play a role in the uptake of bacteria or viruses (6).

DC-SIGN belongs to the mannose (Man) receptor family. Interactions between this family of receptors and pathogens usually occur through mannose-rich surface components such as the mannose-capped cell wall on M. tuberculosis and the mannose motif expressed in HIV. However, in another example, DC-SIGN binds to other sugar components that lack mannose-related epitopes, such as the Lex structure (Galbeta1_4(Fuc{alpha}1–3)GlcNAcbeta) (galactose-fucose-N-acetylglucosamine). Recently, a detailed structural study and analysis of DC-SIGN has concluded that ligand structures containing ManGlcNAc and FucGlcNAc residues mediate the strongest binding to DC-SIGN (11). Interestingly, all three of these latter structures contain GlcNAc, suggesting that the GlcNAc rather than other sugar residues such as mannose may play a central role in mediating interaction of these ligands with DC-SIGN.

Recently, we have found that DC-SIGN promotes adherence and phagocytosis of a nonpathogenic Escherichia coli K12 strain and a lgtB mutant (Fig. 1) from Neisseria gonorrhoeae (GC) in both DCs and HeLa cells expressing human DC-SIGN Ag (HeLa-DC-SIGN) (12). We further demonstrated that it is the core LPS region of E. coli that interacts with DC-SIGN (13).


Figure 1
View larger version (30K):
[in this window]
[in a new window]
  		FIGURE 1. Structures of inner- and outer-core regions of the LPS or LOS of E. coli K12, S. typhimurium, N. gonorrhoeae, and H. ducreyi and the genes involved in their synthesis. Genes involved in the biosynthesis of core LPS are shown at their approximate site of action (solid line). The sites, which are variably substituted or still under investigation, are indicated by dashed lines. The abbreviations in this figure are: GlcNAc, N-Acetylglucosamine; Glc, glucose; Hep, heptose; Gal, galactose; P, phosphate; PPEtn, phosphoethanolamine; KDO, 2-keto-3-deoxyoctonate; PEA, phosphoethanolamine. It should be noted that E. coli K12, N. gonorrhoeae, and H. ducreyi do not possess O-Ag.

 
LPS is a unique bacterial glycolipid, consisting of three structurally distinct domains: lipid A, the membrane anchor and endotoxic portion of LPS; the core saccharide consisting of a branched chain of nonrepeating hexose and heptose sugars; and the O-Ag side chain, a repeating unit of sugars that extends into the extracellular milieu. The core can be further divided into the outer core (semivariable composition of sugars and linkages among bacterial species and strains) and the inner core (considerably conserved among bacterial species and strains) (Fig. 1). Most enteric bacterial pathogens contain O-Ags as a component of their LPS, and O-Ags can promote resistance to serum killing and phagocytosis, enhancing the pathogenicity of Enterobacteriaceae such as E. coli, Shigella spp., and Salmonella spp (14, 15, 16, 17, 18).

Interestingly, many pathogenic Gram-negative nonenteric bacteria, such as N. gonorrhoeae, Haemophilus influenzae, Neisseria meningitidis, and Haemophilus ducreyi, do not contain O-Ag, and therefore their dominant outer membrane lipid is referred to as lipo-oligosaccharide (LOS) (Fig. 1). In the case of GC, the genes encoding the glycosyltransferases responsible for the addition of each sugar to the GC LOS have been identified by several laboratories (19, 20), in which the genes lgtA to lgtE, encoding glycosyltransferases, are located in a single cluster. The function of each of these glycosyltransferases is to elongate the main chain of the GC LOS (Fig. 1). In addition, this bacterium is capable of switching from one LOS phenotype to another in vivo to survive (21).

The core LPS regions of the Gram-negative bacteria E. coli, Salmonella enterica serovar Typhimurium (S. typhimurium), N. gonorrhoeae, and H. ducreyi are well-defined chemically and genetically. In this study, we used isogenic pairs of core LPS or LOS mutants to determine the epitopes within the core LPS or LOS of these four species that function as a ligand for DC-SIGN.

Consistently, we found that the GlcNAc sugar residues within the core LPS play a major role in targeting DC-SIGN receptor to each of the bacterial pathogens.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Bacterial strains

GC strain MS11 was cultured and maintained as previously described (22). GC with LOSb (lacto-N-neotetraose, variant C or wild type) and lgtF phenotypes were used (23, 24, 25). MS-lgtF is an isogenic derivative of wild-type GC strain MS11. GC strains {Delta}3, I3, {Delta}2, and {Delta}4 are isogenic LOS mutants of GC F62 (wild-type) and contain mutations within the lgtD, lgtB, lgtA, and lgtE. They were gifts from Dr. E. Gotschlich (Rockefeller University, New York, NY) (Fig. 1 and Table I) (19, 26). For all GC, only Opa– and pilus– variants were used.


View this table:
[in this window]
[in a new window]
  		Table I. Bacterial strains used in this study

 
E. coli K12 lacking O-Ag, has recently been demonstrated to bind DC-SIGN (12). E. coli K12 strain CS180 contains core LPS but lacks O-Ag (27). Two derivatives of CS180, CS1861 (CS180 harboring pSS37, a plasmid containing all of the genes necessary for the expression of the Shigella dysenteriae 1 O-Ag), and a deep rough mutant CS2429 (waaC), lacking both O-Ag and most of core, were used to assess the role of LPS in bacterial-DC cell interactions (27, 28, 29). Isogenic mutants of CS180 are listed in Table I (30, 31, 32, 33, 34).

Enterohemorrhagic E. coli (EHEC-43895) was purchased from the American Tissue Cell Cultures (ATCC). A naturally occurring rough strain of EHEC, MA6, was originally isolated from beef sold in Malaysia (35). E. coli GR-12, an uropathogenic E. coli (UPEC), was originally isolated from a patient with pyelonephritis (36). SMB-316, a derivative of E. coli GR-12, is a rough strain, in which genes for O-Ag syntheses have been deleted (14). These strains were provided by Dr. S. Hull (Baylor College of Medicine, Houston, TX). E. coli strains were cultured on Luria-Bertani medium (LB) supplemented with 1.5% agar at 37°C overnight.

A defined set of S. typhimurium mutants was supplied from Salmonella Genetic Stock Centre (SGSC) at the University of Calgary (Fig. 1 and Table I) (37, 38). Isolates were grown and maintained in a manner identical with E. coli.

H. ducreyi strain A77, a strain from the Pasteur Institute collection (39), was provided by Dr. R. S. Munson (Columbus Children’s Research Institute and Departments of Pediatrics and Microbiology, The Ohio State University, Columbus, OH). Its LOS lacks the sialic acid substitution as well as the galactose residue found in the N-acetyllactosamine portion of strain 35000HP, a human-passaged variant of 35000, described previously (39). A77-pRSM1955, a derivative of A77, carries the pRSM1955 plasmid coding the galactosyltransferase II gene, and can express the N-acetyllactosamine portion of the LOS core from strain 35000HP. Strains were cultured on GC based-plates (Difco) supplemented with 1% hemoglobin (USB) and 1% IsovitaleX.

pEXI is E. coli K12 HB101 (same core LPS structure as CS180) expressing the opacity (Opa) protein I from N. gonorrhoeae. pGEM is E. coli K12 HB101 harboring the cloning vector only (40). Opa I is ligand for the CEACAM3 (CD66d) receptor and promotes phagocytosis of bacteria by neutrophils and HeLa-CEACAM3 (41, 42).

Reagents

Single sugars: GlcNAc and GalNac; oligosaccharides: GlcNAc-Gal-Glc, Gal-GlcNAc, Fuc-GlcNAc, and GlcNAc-Gal-OMe (beta-D-GlcNAc-(1 > 6)-beta-D-Gal-(1 > 4)-D-Glc, beta-D-Gal-(1 > 4)-D-GlcNAc, {alpha}-L-Fuc-(1 > 3)-D-GlcNAc, and beta-D-GlcNAc-(1 > 3)-beta-D-Gal-1-O-methylated), and compound saccharides: glucan and mannan, were purchased from Sigma-Aldrich.

Culture cell lines

HeLa-DC-SIGN cells were generated by transfecting HeLa cells with human DC-SIGN cDNA followed by selection for stable surface DC-SIGN expression as described previously (43, 44).

HeLa-CEACAM3 cells were generated by transfecting HeLa cells with human CEACAM3 (CD66d) cDNA followed by selection for stable surface CD66 expression as described previously (42, 45).

Adherence and phagocytosis assays

The assays for adherence and phagocytosis have been described previously (41, 45). Briefly, HeLa cells were plated in 24-well plates. Cells were suspended in RPMI 1640 with 2% FCS at a concentration of 4 x 105/ml. A total of 0.5 ml each of these cell suspensions was added to 24-well plates and after addition of 50 µl of bacterial suspensions at a concentration of 4 x 107 CFU/ml, the cells were allowed to incubate for 2.5 h at 37°C in the presence of 5% CO2. The cell monolayers were then washed three times with PBS. The number of associated bacteria (adherent and internalized) per cell was quantified by washing the cells three times with RPMI 1640 containing 2% FCS and plating the culture after the cells were lysed by 0.5% saponin (Calbiochem).

To determine the internalization of bacteria, gentamicin, which kills extracellular bacteria but cannot penetrate into host cells, was added into each well to a final concentration of 100 µg/ml, and the cultures were incubated for 90 min. The cells were suspended in PBS containing 0.5% saponin, diluted, and plated on GC or LB plates. The level of internalization of bacteria in HeLa cells was calculated by determining the CFU recovered from lysed cells. All experiments were performed in triplicate, and data was expressed as mean ± SEs. Statistical significance was calculated using the Student t test.

For the inhibition assay, the saccharides including LPS and core LPS (hydrolyzed LPS oligosaccharide core) were added at a concentration of 200 µg/ml, oligosaccharides at a concentration of 400 µg/ml, DC-SIGN-like protein at a concentration of 10 µg/ml, and mannan at a concentration of 400 µg/ml, 20 min before the addition of bacteria. The concentrations used in the experiments were based on our preliminary data, in which these concentrations would influence neither the survival of bacteria nor the HeLa cells, nor the interaction between pEXI and HeLa-CEACAM3 (as also shown in Fig. 7B).


Figure 7
View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 7. Inhibition of the core-LPS-DC-SIGN interaction using purified LPS, oligosaccharide, and a DC-SIGN-like molecule. A, Phagocytosis of E. coli CS180 (control) by HeLa-DC-SIGN was used to assess core-LPS-DC-SIGN interaction as shown in Fig. 3. Mannan was used as a positive control for inhibition of the core-LPS-DC-SIGN interaction as shown previously (12 13 ). Reagents at a concentration for LPS and core LPS of 200 µg/ml, oligosaccharides of 400 µg/ml, His-Mermaid of 10 µg/ml, and mannan of 400 µg/ml were added to medium for 20 min before addition of bacteria. B, The interaction of pEXI and the HeLa-CEACAM3 (CD66d) cell line was used as a control to examine whether the reagents influence the survival of either E. coli or HeLa cells, consequently influencing interaction results. pGEM/medium; pGEM vector with no insert instead of pEXI was used for a negative control. C, E. coli CS180 and E. coli CS1861 were incubated with 10 µg of FITC-Mermaid for 30 min and washed once with PBS. The binding ability of FITC-labeled Mermaid to bacteria was measured by flow cytometry. The fluorescent intensities of E. coli CS180 and E. coli CS1861 are shown in nonfilled and filled curves, respectively.

 
Purification of LPS and core LPS

A modified phenol/water extraction procedure adapted from Westphal and Jann (46) was used for LPS purification. Briefly, E. coli and N. gonorrhoeae were suspended in water and heated to 65°C. An equal volume of phenol heated to 65°C was added to the bacterial suspension and the mixture was incubated at 65°C for 1 h with stirring. After centrifugation, the aqueous phase was recovered and the interfacial/phenol phase material was re-extracted once with water. Aqueous phases were ultrafiltered three times through a 100-kDa molecular mass, ultrafiltration device (Millipore), ultracentrifuged at 100,000 x g for 6 h and lyophilized.

To produce core oligosaccharide (free of lipid A), a variation of a previously published method was used (47). Briefly, purified LPS was hydrolyzed in 0.1 M sodium acetate (NaOAc) (pH 4.5), for 4 h at 100°C. The mixture was centrifuged through a Dowex 50WX8 column (Sciencelab.com, Inc.) to remove sodium. The eluted LPS mixture (including both core LPS and lipid A) was then ultrafiltered through a 100-kDa molecular mass ultrafiltration device to remove the lipid A molecule. The remaining material, considered core LPS, was lyophilized.

Expression, purification, and FITC conjugation of His-Mermaid

Mermaid is usually secreted by the Laxus oneistus onto the posterior, bacterium-associated region of this marine nematode. Recently, Mermaid has been identified as a DC-SIGN-like protein. It is expected that the interaction of Mermaid with bacteria induces symbiont aggregation in seawater leading to symbiosis (48). His-Mermaid was expressed and purified as described previously (48). FITC-conjugated His-Mermaid (FITC-His-Mermaid) was obtained with the FITC Labeling kit (Calbiochem) according to the manufacturer’s instructions. The molar ratio of FITC:His-Mermaid was 3:9 and FITC conjugation did not affect the cell agglutination properties of Mermaid (data not shown).

FITC-His-Mermaid-binding assay

E. coli CS180 and E. coli CS1861 suspended in PBS at an OD of 0.2 were incubated with 10 µg of FITC-His-Mermaid for 30 min and washed once with PBS. The binding ability of FITC-His-Mermaid to bacteria was measured with fluorescent intensity using flow cytometry.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
Rough strains of E. coli do not equally bind to DC-SIGN

We recently demonstrated that core LPS from E. coli is a ligand for DC-SIGN by showing that some rough strains of K-12 and uropathogenic E. coli, but not their isogenic smooth derivatives, interact with HeLa cells expressing DC-SIGN (HeLa-DC-SIGN) (13). We were subsequently interested in determining whether rough variants of other E. coli strains were able to interact with DC-SIGN. To test this, three smooth and rough pairs of E. coli strains (E. coli K12, CS1861/CS180; UPEC, GR-12/SMB-316; and EHEC, 43895/MA6) were examined for their ability to interact with HeLa-DC-SIGN. Fig. 2 shows that rough E. coli CS180 and SMB-316 promote strong DC-SIGN-mediated phagocytosis typical of our previous observations. All three smooth strains were resistant to phagocytosis mediated by DC-SIGN consistent with previous results. Unexpectedly, the rough derivative of the EHEC strain, MA6, was also resistant to phagocytosis. This result suggests that loss of the LPS O-Ag region in some E. coli isolates is not sufficient for the binding to DC-SIGN, and indicates that a specific epitope within the core LPS may be necessary for binding. It is known that the composition of core LPS, especially the outer core saccharide, can vary among different E. coli. It should be noted that most EHEC such as the 43895 and MA6 produce Shiga toxin, which could influence the ability of host cells to phagocytose the bacteria. However, we did not observe significant morphological changes, such as changes of cell shape and/or detachment of HeLa cells from plates after 2.5 h of incubation with these two bacterial strains. In addition, the results from CS1861/CS180 and GR-12/SMB-316 presented here were regarded as controls because similar data were published (13).


Figure 2
View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 2. HeLa-DC-SIGN cells phagocytose rough strains of E. coli and UPEC, but not the rough EHEC. The adherence (A) and phagocytosis (B) of three pairs of E. coli: K-12 (CS180 and CS1861), EHEC (43895 and MA6), and uropathogenic E. coli (GR12 and SMB-316), with HeLa and HeLa-DC-SIGN were performed by incubating cell lines for 2.5 h with the indicated E. coli strains and by killing the extracellular bacteria with 100 µg/ml (final concentration) gentamicin as described previously (12 13 ). The number of phagocytosed bacteria was determined by counting CFUs recovered following gentamicin treatment.

 
Examination of the interaction of core LPS mutants of E. coli with HeLa-DC-SIGN

To test the idea that a specific epitope within the core LPS might be involved in interaction with DC-SIGN, we attempted to define the core LPS epitope by using a set of core LPS mutants from E. coli K12. Adherence and phagocytosis of the E. coli mutants (Table I) with HeLa-DC-SIGN is depicted in Fig. 3. Four observations were made from these results.


Figure 3
View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 3. Interaction of core LPS mutants of E. coli with HeLa-DC-SIGN. The adherence (A) and internalization (B) of E. coli K12 strains (Table I), by HeLa and HeLa-DC-SIGN, were performed with the same procedures as in Fig. 2.

 
1) The core LPS of E. coli mediates the interaction with DC-SIGN. Our previous data (13) and Fig. 3 confirm that the waaR mutant does not interact with DC-SIGN as well as its parent strain CS180, suggesting that it is the core LPS rather than other components on the E. coli surfaces interacting with DC-SIGN. Furthermore, the mutants waaO, waaG, and waaC, expressing decreasing lengths of LPS core, lose the ability to promote phagocytosis by HeLa-DC-SIGN. This is not observed with the LPS core side-chain mutants, waaB, waaQ, waaY, and waaP. The data suggest that the epitope for DC-SIGN resides in the main chain of the outer core of LPS.

2) WaaU does not play a role in the interaction. As shown above, the waaR mutant loses most of the ability to interact with DC-SIGN, indicating that either GlcNAc, GlcIII, or HepIV plays a role in interacting with DC-SIGN. If GlcNAc is an epitope, exposure of GlcNAc should increase interaction with DC-SIGN. To test that hypothesis, we examined the ability of the waaU mutant, which likely encodes the enzyme responsible for transfer of GlcNAc or HepIV to GlcIII, to interact with DC-SIGN. The result observed for the waaU mutant was indistinguishable from that of the parent strain, CS180 in terms of phagocytosis by HeLa-DC-SIGN cells. There are two explanations for this result. First, the enzymatic product of the waaU has not yet unequivocally been shown to be a HepIV transferase that adds the beta-GlcNAc on HepIV, although there is some biochemical data to support this assertion (49, 50). Therefore, it is possible that waaU does not code for HepIV transferase. Second, there may be other beta-GlcNAc epitopes on the side chain of the core LPS between waaR and waaC of E. coli, as discussed below.

3) Interaction with DC-SIGN could be mediated by other epitopes on the side chain of core LPS. Although all three waaR, waaO, and waaG mutants are resistant to phagocytosis by HeLa-DC-SIGN, this resistance is not complete when compared with waaC, suggesting a role for some sugars in the core between heptose and the end of the LPS. It has been shown there is another beta-GlcNAc epitope in E. coli R3 (49, 50), however, it is not clear whether E. coli K12 possesses the beta-GlcNAc epitopes. Based on the E. coli LPS core R3 chemical structure, it is predicted that a beta-GlcNAc residue is present between the core saccharide defined by the action of the WaaF and WaaR transferases, which could be demonstrated by testing a waaF mutant. Unfortunately, this mutant is unavailable for testing. However, the data from a S. typhimurium waaF strain presented below suggested this possibility. Interspecies complementation experiments transferring the waaF gene from E. coli to Salmonella restore wild-type phenotypes (J. Klena and A. Schnaitman, unpublished results).

4) The effect of length of core LPS on binding ability to DC-SIGN. The results from Fig. 3 show that the shorter the core LPS, the lesser interaction was observed with DC-SIGN, suggesting that the interaction of core LPS with DC-SIGN is not mediated by specific epitopes, but rather by a specific length of the core LPS. The data obtained using Salmonella core LPS mutants (discussed below) are also consistent with that speculation. However, the data obtained with the LOS mutants of GC do not seem to support this hypothesis (see below).

In short, from these E. coli mutants, while suggesting that an outer core saccharide such as GlcNAc is important for DC-SIGN interaction, the data are not sufficiently convincing to demonstrate that a specific epitope in the LPS core is responsible for the interaction with DC-SIGN.

The core of Salmonella LPS is also a ligand for DC-SIGN

We have established that the core LPS of E. coli interacts with DC-SIGN (13) and the results of Fig. 3 support those conclusions. To determine whether the core LPS of other Gram-negative bacteria can also interact with DC-SIGN, we examined the interaction of the rough strains of S. typhimurium with HeLa-DC-SIGN. In addition, because the core LPS of E. coli and S. typhimurium are similar and the LPS mutants of S. typhimurium are reasonably well defined (37, 38), we used a set of core LPS mutants from S. typhimurium to examine whether a specific epitope within core LPS that is responsible for interacting with DC-SIGN can be identified and how comparable these are results to those observed for E. coli. Consistent with the results obtained for E. coli (Fig. 2) (13), the rough S. typhimurium strain (waaL mutant) promoted a typical DC-SIGN-mediated adherence and phagocytosis, while the wild-type strain resisted phagocytosis by HeLa-DC-SIGN (Fig. 4). Furthermore, the deletion of GlcNAc epitope in the waaK mutant reduced the ability of S. typhimurium to interact with DC-SIGN. Interestingly, phagocytosis of the S. typhimurium mutants by HeLa-DC-SIGN was consistent with the idea that the lengthier the core LPS is, the greater the ability to promote phagocytosis (WaaL > WaaK > WaaJ or I > WaaG > WaaF > WaaC = 0). However, it remains unclear whether or what kind of side-chain epitopes exist between the enzymatic products of WaaL and WaaC. In summary, data from S. typhimurium also indicated that GlcNAc plays a role in mediating interaction with DC-SIGN. However, without knowing the side chain of the core LPS in S. typhimurium, we could not rule out whether other components and mechanisms play a part in interaction with DC-SIGN. It should be noted that in comparison with E. coli (Fig. 3), S. typhimurium showed a limited invasion of HeLa cells, which is not mediated by core LPS-DC-SIGN interaction. Salmonella species are known to possess invasive properties that are part of their virulence factors. In addition, some mutants such as the waaC mutant, show an increase in their ability to bind, but not promote phagocytosis, to HeLa cells. This result is not surprising because the outer core may block access to surface structures that are exposed in a deep-rough defective LPS core (waaC). This could result in the increasing expression of other outer membrane proteins, which might be the ligand to some components in HeLa cells.


Figure 4
View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 4. The core region of LPS is required to mediate the S. typhimurium-DC-SIGN interaction. The adherence (A) and internalization (B) of the wild-type S. typhimurium and the core LPS mutants were examined and measured with the same procedures as in Fig. 2.

 
HeLa-DC-SIGN cells bind to and phagocytose the lgtB mutant of N. gonorrhoeae

We had attempted to use the most defined core LPS mutant series so far described for bacteria to determine the possible specific epitopes that interact with DC-SIGN. Although the data obtained from the E. coli and Salmonella experiments above indicate that GlcNAc plays a significant role in interacting with DC-SIGN, neither set of mutants could provide conclusive evidence that GlcNAc is the specific epitope. The major problem is that in both E. coli and S. typhimurium, GlcNAc is the last residue at the nonreducing end of the core saccharide of the rough strains, so that the deletion of the GlcNAc also shortens the core LPS. Therefore, it could be argued that the reduced binding to DC-SIGN may be due to the shortening of core LPS rather than deletion of specific sugar residues. To demonstrate that this is not the case, we examined the interaction of HeLa-DC-SIGN with another set of strains, N. gonorrhoeae. As shown in Fig. 1, the GlcNAc residue is centrally located within the outer core of the N. gonorrhoeae LOS. If the GlcNAc is necessary and sufficient for DC-SIGN binding, only LOS mutants, such as lgtB (Fig. 1) that has the GlcNAc epitope exposed should interact with DC-SIGN. Thus, we used the following genetic derivatives of GC strain F62: wild-type, lgtD, lgtB, lgtA, and lgtE, and strain MS11: wild-type and lgtF, to examine the interaction of GC LOS with HeLa-DC-SIGN. We also used two MS11GC strains because we did not have an access to lgtF mutant from F62. As expected, only GC strain lgtB mutant promoted DC-SIGN-mediated binding and phagocytosis, i.e., HeLa-DC-SIGN but not HeLa cells phagocytosed the lgtB strain (Fig. 5). This is consistent with results reported previously for Neisseria (12, 51).


Figure 5
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 5. The exposure of N-acetylglucosamine within the LOS of N. gonorrhoeae results in interaction with DC-SIGN. The procedures for examining the adherence (A) and phagocytosis (B) of HeLa and HeLa-DC-SIGN with Neisserial strain F62 (lgtF mutant from MS11) and their isogenic LOS-mutated strains were performed as described in the legend of Fig. 2.

 
In conclusion, these results strongly suggest that it is the GlcNAc epitope located within the main chain of the core LOS/LPS that mediates the interaction with DC-SIGN. The data also suggest that the overall core length is not critical as the position of the GlcNAc varies between the three Gram-negative bacteria tested.

Shielding the LOS core GlcNAc with other sugar residues blocks the interaction of H. ducreyi with DC-SIGN

Although N. gonorrhoeae data clearly demonstrate that GlcNAc is an epitope promoting the interaction of GC with DC-SIGN, it is possible, when an LOS gene such as lgtB is deleted, the expression of other genes in the operon might also be affected, thus altering the binding to DC-SIGN. To address this concern, we used a set of H. ducreyi strains, A77 and A77-pRSM1955. The strain A77 naturally lacks galactosyltransferase II (39), exposing core LOS GlcNAc (a natural lgtB mutant). A77-pRSM1955 is the A77 strain containing the pRSM1955 plasmid expressing the N-acetyllactosamine portion of the LOS core from strain 35000HP (Fig. 1) (39). Based on the hypothesis above, A77 should interact with DC-SIGN, which would be inhibited when its GlcNAc epitope is covered. The result showed that A77 was phagocytosed by HeLa-DC-SIGN very well, but A77-pRSM1955 lost its ability to promote the phagocytosis by HeLa-DC-SIGN (Fig. 6). However, it should be noted that A77 interacts with HeLa cells and that expression of N-acetyllactosamine also inhibits DC-SIGN-independent interactions between A77 and HeLa cells.


Figure 6
View larger version (17K):
[in this window]
[in a new window]
  		FIGURE 6. Blocking of GlcNAc epitopes blocks the interaction of H. ducreyi with DC-SIGN. The interaction of strains of H. ducreyi, A77 and A77-pRSM1955, with HeLa and HeLa-DC-SIGN was examined as described in the legend of Fig. 2. A, Adherence. B, phagocytosis.

 
The role of purified LPS, oligosaccharide, and DC-SIGN-like molecule in core-LPS-DC-SIGN interaction

The results presented so far were generated from interactions between bacteria expressing defined LPS mutations and DC-SIGN-expressing HeLa cells. We next addressed the interaction of the LPS and DC-SIGN using purified molecules (LPS, core LPS, and DC-SIGN).

1) Purified LPS and core LPS of lgtB mutant of N. gonorrhoeae reduce the core-LPS-DC-SIGN interaction. The purified LPS and core LPS from E. coli CS180, and a lgtB mutant of N. gonorrhoeae (Fig. 7A), were tested for their ability to inhibit the core-LPS-DC-SIGN interaction. Because the purified LPS may potentially affect either the bacteria or HeLa cells, the Opa I-expressing E. coli (pEXI) and CEACAM3 (CD66d) expressing HeLa cells (HeLa-CEACAM3) were used as controls. We have demonstrated previously that interaction of pEXI with HeLa-CEACAM3 promotes a typical phagocytosis of pEXI (42, 45). Fig. 7A showed that only purified LPS, especially the purified core of the lgtB (I3) mutant of N. gonorrhoeae, inhibits core-LPS-DC-SIGN interaction but not the pEXI-HeLa-CEACAM3 interaction (Fig. 7B). However, no inhibition was evident when purified LPS and core LPS from E. coli CS180 was used. E. coli CS180 has exhibited a strong interaction with HeLa-DC-SIGN (Fig. 3) (12, 13)

2) The oligosaccharides containing the GlcNAc in a specific orientation, but not single sugar residues, inhibit the core-LPS-DC-SIGN interaction. We have proposed that GlcNAc-exposed core LPS interacts with DC-SIGN. To determine whether GlcNAc-containing oligosaccharides would inhibit the core-LPS-DC-SIGN interaction, four oligosaccharides (GlcNAc-Gal-Glc, Gal-GlcNAc, Fuc-GlcNAc, and GlcNAc-Gal-OMe), two single sugar residues (GlcNAc and GalNAc), and one sugar compound (glucan) were tested. Mannan, which inhibits core-LPS-DC-SIGN interaction as shown previously (12, 13), was used as a positive control for inhibition. Fig. 7A showed that GlcNAc-Gal-Glc and Fuc-GlcNAc inhibit the core-LPS-DC-SIGN interaction, while Gal-GlcNAc and GlcNAc-Gal-OMe marginally influence the interaction. However, we did not have an access to the GlcNAc-Gal molecule, therefore we could not assess whether it is the specific methylation of this molecule that influences the outcome. It is also of considerable interest to note that the trisaccharide of GlcNAc-Gal-Glc is the same sequence as the terminal three residues of core LPS from lgtB (I3) mutant of N. gonorrhoeae (Fig. 1). Fuc-GlcNAc-mediated inhibition of DC-SIGN has been reported previously (11).

3) A DC-SIGN-like molecule binds to the core LPS and inhibits the core LPS-DC-SIGN interaction. The two experiments described above were conducted from the perspective of the ligand. We wanted to determine whether the purified DC-SIGN receptor plays a role in the core LPS-DC-SIGN interaction. However, DC-SIGN is a transmembrane protein and it is possible that purified DC-SIGN will not retain its biological functions. Recently, we contributed to the identification of Mermaid, a marine nematode Ca2+-dependent lectin whose carbohydrate recognition domain shares both structural and functional similarity with that of DC-SIGN (48). Therefore, we tested the ability of a recombinant form of Mermaid to bind CS180, thereby inhibiting the core LPS-DC-SIGN interaction. As shown in Fig. 7A, FITC-His-Mermaid inhibits the core LPS-DC-SIGN interaction. Furthermore, FITC-His-Mermaid binds to CS180 stronger than CS1861, indicating that this DC-SIGN-like protein is likely to directly interact with GlcNAc-exposing core LPS.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
We have previously demonstrated that transfected HeLa cells expressing DC-SIGN, but not untransfected HeLa cells, were able to bind and avidly internalize rough E. coli (12, 13). Using sets of core LOS/LPS mutants from four different Gram-negative bacteria, we have demonstrated that a GlcNAc residue within the main chain of the core LOS/LPS plays a major role in interacting with DC-SIGN. The dependence on GlcNAc is evident even though each of these bacteria has its own characteristic interaction with DC-SIGN.

DC-SIGN belongs to the mannose receptor family. However, two of three structure motifs: Lex structure (Galbeta1–4(Fuc{alpha}1–3)GlcNAcbeta), ManGlcNAc, and FucGlcNAc that have previously been shown to bind to DC-SIGN (11), do not contain mannose epitopes but all three do contain GlcNAc. Similarly, the core LPS from E. coli K12, H. ducreyi, N. gonorrhoeae, and S. typhimurium do not contain either mannose or fucose (Fig. 1), but GlcNAc is a part of the core LOS/LPS region in each species. We have shown that when the GlcNAc LOS/LPS epitope is removed, the ability of the bacteria to interact with DC-SIGN is decreased or lost and therefore GlcNAc-containing LOS/LPS is critical in phagocytosis mediated by DC-SIGN. Furthermore, the role of GlcNAc has not been much considered in earlier studies (8, 11, 52, 53).

We have taken advantage of biologically, structurally, and genetically well-defined core LOS/LPS mutants to demonstrate the role of GlcNAc in DC-SIGN binding. In other systems, such as the glycosylated gp120 of HIV and DC-SIGN, it is technically challenging to create specific sugar synthesis null mutations, therefore complicating epitope identification. In addition, other studies have relied on the biosynthesis of specific sugar epitopes based on the possible structural features. The use of bacterial core LOS/LPS to investigate DC-SIGN interactions represents an important step in this area.

The question now becomes whether GlcNAc directly binds to DC-SIGN or forms a specific motif with other sugar residues that subsequently interacts with DC-SIGN. To answer this question, we used purified LPS and core LPS, four GlcNAc-containing oligosaccharides, GlcNAc, GalNAc, glucan, mannan (positive control) (12, 13), and the Mermaid (a DC-SIGN-like molecule) to block the interaction between the core LPS and DC-SIGN. The interaction of each molecule with DC-SIGN-expressing HeLa cells revealed that mannan most effectively competed with core LPS to inhibit phagocytosis, followed by Mermaid, GlcNAc-Gal-Glc/Fuc-GlcNAc, then the core LPS of I3, the LPS of I3/Gal-GlcNAc/GlcNAc-Gal-OMe, and glucan. The LPS of CS180, the core LPS of CS180, GlcNAc, and GalNAc showed no inhibition of phagocytosis. Collectively, we can deduce the following information from these data. 1) Oligosaccharides containing the GlcNAc with the correct configuration inhibit the core-LPS-DC-SIGN interaction as shown by GlcNAc-Gal-Glc and core LPS of I3, but not Gal-GlcNAc. It must be also recognized that the oligosaccharide sequence of GlcNAc-Gal-Glc is the same sequence as the terminal three residues of core LPS from I3. In addition, we believe that the Fuc-GlcNAc-mediated inhibition is due the fucose residue as demonstrated previously by other investigators (11). 2) Conformation of the individual saccharides may also play a role in the inhibition of core-LPS-DC-SIGN interaction. Both CS180 and I3 use their core LPS to bind to HeLa-DC-SIGN, however, only purified LPS and core LPS of I3 inhibited the core-LPS-DC-SIGN interaction. We speculate that the loss of the ability for inhibition is due to conformational changes during the purification processes. 3) A compound with two and more oligosaccharides is necessary to be functional. Our data showed that GlcNAc-Gal-Glc and Fuc-GlcNAc rather than GlcNAc or GalNAc inhibit the core-LPS-DC-SIGN interaction. Similarly it is mannan, made of multiple mannoses rather than mannose alone, that inhibits most interactions promoted by the mannose receptor family, such as interaction inhibition of HIV with DC-SIGN (54).

The discovery of DC-SIGN as a receptor for core LPS of E. coli was fortuitous (12, 13). This observation with the results from the current study may explain why bacterial O-Ags are antiphagocytic. It is known that one major role of O-Ags in the pathogenicity of Enterobacteriaceae such as E. coli, Shigella, Klebsiella, and Salmonella is to promote resistance to serum killing and phagocytosis (14, 15, 16, 17, 18). Our results provide a potential mechanism, suggesting that O-Ag functions as an anti-phagocytic factor by simply shielding the ligand necessary for host cell contact. In the case of GC, only a lgtB mutant binds DC-SIGN, while the wild-type strain is poorly recognized by DC-SIGN, suggesting that GC may evolve mechanisms to avoid binding to DC-SIGN and killing by phagocytosis.

Using the various core LOS/LPS of these bacterial species to interact with host cells may represent an alternative approach to averting the innate immune system. For example, GC uses a frame-shifting mechanism at the genetic level, to express different LOS molecules at the phenotypic level. Several of these phenotypes mimic human cell surface structures such as gangliosides (23, 55, 56). Furthermore, GC LOS interacts with complement receptor 3 (CR3) from female human cervical epithelia (57, 58), and the asialoglycoprotein receptor on human sperm (59). In vivo, gonococcal LOS can switch from one phenotype to another in a human challenge model (23), suggesting that different LOS phenotypes could interact with various receptors to adapt to specific host environments. Therefore, different Gram-negative bacterial pathogens appear to have evolved unique ways for handling the human innate immune system.

In contrast, N. gonorrhoeae, N. meningitidis, Moraxella catarrhalis, H. influenzae, E. coli, Campylobacter jejuni, and Salmonella can colonize mucosal surfaces, but quite often these events are asymptomatic, suggesting that innate immune defenses are able to control these pathogens. DC-SIGN could be one of the innate immune receptors because internalization via DC-SIGN is opsonin-independent phagocytosis.

It is generally thought that ancestral bacteria possessed only LOS and that bacterial O-Ags, like adaptive immunity, were acquired as a consequence of pathogen-host coevolution. Bacteria appear to have evolved several independent mechanisms to avoid or exploit this recognition Therefore, from an evolutionary point of view, the interaction of bacterial core LOS/LPS and the innate immune receptor, DC-SIGN, may represent a primitive interaction between microbial pathogens and the professional phagocytic host cells.


   Acknowledgments
 
We thank Drs. Ines Chen and Margaret Bauer for useful suggestions and editorial comments on the manuscript. We are indebted to Margaret Bauer, Robert Munson, and Stanley Spinola for insightful scientific and technical advice.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Public Health Service Grant R01AI 47736 (to T.C.). Back

2 Address correspondence and reprint requests to Dr. Tie Chen, Department of Biomedical Sciences, College of Medicine, University of Illinois at Chicago, 1601 Parkview Avenue, Rockford, IL 61107; E-mail address: tiechen{at}uic.edu or Dr. John Klena, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand; E-mail address: paua4T{at}yahoo.com Back

3 Abbreviations used in this paper: DC, dendritic cell; DC-SIGN, DC-specific ICAM nonintegrin; LOS, lipo-oligosaccharide; Opa, opacity. Back

Received for publication June 28, 2005. Accepted for publication June 19, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Agrawal, A., J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334. [Medline]
  2. Starnbach, M. N., R. J. Collier. 2003. Anthrax delivers a lethal blow to host immunity. Nat. Med. 9: 996-997. [Medline]
  3. Tailleux, L., O. Schwartz, J. L. Herrmann, E. Pivert, M. Jackson, A. Amara, L. Legres, D. Dreher, L. P. Nicod, J. C. Gluckman, et al 2003. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197: 121-127. [Abstract/Free Full Text]
  4. Maeda, N., J. Nigou, J. L. Herrmann, M. Jackson, A. Amara, P. H. Lagrange, G. Puzo, B. Gicquel, O. Neyrolles. 2003. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 278: 5513-5516. [Abstract/Free Full Text]
  5. Zamze, S., L. Martinez-Pomares, H. Jones, P. R. Taylor, R. J. Stillion, S. Gordon, S. Y. Wong. 2002. Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor. J. Biol. Chem. 277: 41613-41623. [Abstract/Free Full Text]
  6. van Kooyk, Y., T. B. Geijtenbeek. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3: 697-709. [Medline]
  7. Geijtenbeek, T. B., S. J. Van Vliet, E. A. Koppel, M. Sanchez-Hernandez, C. M. Vandenbroucke-Grauls, B. Appelmelk, Y. Van Kooyk. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197: 7-17. [Abstract/Free Full Text]
  8. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597. [Medline]
  9. Engering, A., S. J. Van Vliet, T. B. Geijtenbeek, Y. Van Kooyk. 2002. Subset of DC-SIGN+ dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood 100: 1780-1786. [Abstract/Free Full Text]
  10. McDonald, D., L. Wu, S. M. Bohks, V. N. KewalRamani, D. Unutmaz, T. J. Hope. 2003. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295-1297. [Abstract/Free Full Text]
  11. Guo, Y., H. Feinberg, E. Conroy, D. A. Mitchell, R. Alvarez, O. Blixt, M. E. Taylor, W. I. Weis, K. Drickamer. 2004. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 11: 591-598. [Medline]
  12. Zhang, P., O. Schwartz, M. Pantelic, G. Li, Q. Knazze, C. Nobile, M. Radovich, J. He, S. C. Hong, J. Klena, T. Chen. 2006. DC-SIGN (CD209) recognition of Neisseria gonorrhoeae is circumvented by lipooligosaccharide variation. J. Leukocyte Biol. 79: 731-738. [Abstract/Free Full Text]
  13. Klena, J., P. Zhang, O. Schwartz, S. Hull, T. Chen. 2005. The core lipopolysaccharide of Escherichia coli is a ligand for DC-SIGN (CD209) receptor. J. Bacteriol. 187: 1710-1715. [Abstract/Free Full Text]
  14. Burns, S. M., S. I. Hull. 1998. Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect. Immun. 66: 4244-4253. [Abstract/Free Full Text]
  15. Cortes, G., N. Borrell, B. de Astorza, C. Gomez, J. Sauleda, S. Alberti. 2002. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect. Immun. 70: 2583-2590. [Abstract/Free Full Text]
  16. Murray, G. L., S. R. Attridge, R. Morona. 2003. Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz. Mol. Microbiol. 47: 1395-1406. [Medline]
  17. Morona, R., C. Daniels, L. Van Den Bosch. 2003. Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence. Microbiology 149: 925-939. [Abstract/Free Full Text]
  18. Russo, T. A., B. A. Davidson, U. B. Carlino-MacDonald, J. D. Helinski, R. L. Priore, P. R. Knight, 3rd. 2003. The effects of Escherichia coli capsule, O-antigen, host neutrophils, and complement in a rat model of Gram-negative pneumonia. FEMS Microb. Lett. 226: 355-361. [Medline]
  19. Gotschlich, E.. 1994. Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide. J. Exp. Med. 180: 2181-2190. [Abstract/Free Full Text]
  20. Danaher, R. J., J. C. Levin, D. Arking, C. L. Burch, R. Sandlin, D. C. Stein. 1995. Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation. J. Bacteriol. 177: 7275-7279. [Abstract/Free Full Text]
  21. Kerwood, D. E., H. Schneider, R. Yamasaki. 1992. Structural analysis of lipooligosaccharide produced by Neisseria gonorrhoeae, strain MS11mk (variant A): a precursor for a gonococcal lipooligosaccharide associated with virulence. Biochemistry 31: 12760-12768. [Medline]
  22. Swanson, J.. 1978. Studies on gonococcus infection. XIV. Cell wall protein differences among color/opacity colony variants of Neisseria gonorrhoeae. Infect. Immun. 21: 292-302. [Abstract/Free Full Text]
  23. Schneider, H., J. M. Griffiss, J. W. Boslego, P. J. Hitchcock, K. M. Zahos, M. A. Apicella. 1991. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J. Exp. Med. 174: 1601-1605. [Abstract/Free Full Text]
  24. Swanson, J.. 1991. Some affects of LOS and Opa on surface properties of gonococci. M. Achtman, 3rd, and P. Kohl, 3rd, and C. Marchal, 3rd, and G. Morelli, 3rd, and A. Seiler, 3rd, and B. Thiesen, 3rd, eds. Proceedings of the Seventh International Pathogenic Neisseria Conference 391-396. Walter de Gruyter, Berlin.
  25. Chen, T., J. Swanson, J. Wilson, R. Belland. 1995. Heparin protect Opa+ GC from bactericidal action of normal human serum. Infect. Immun. 63: 1790-1795. [Abstract]
  26. Minor, S. Y., A. Banerjee, E. C. Gotschlich. 2000. Effect of {alpha}-oligosaccharide phenotype of Neisseria gonorrhoeae strain MS11 on invasion of Chang conjunctival, HEC-1-B endometrial, and ME-180 cervical cells. Infect. Immun. 68: 6526-6534. [Abstract/Free Full Text]
  27. Schnaitman, C. A., J. D. Klena. 1993. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol. Rev. 57: 655-682. [Abstract/Free Full Text]
  28. Klena, J., R. S. Ashford, II, C. A. Schnaitman. 1992. Role of Escherichia coli K-12 rfa genes and the rfp gene of Shigella dysenteriae 1 in generation of lipopolysaccharide core heterogeneity and attachment of O antigen. J. Bacteriol. 174: 7297-7307. [Abstract/Free Full Text]
  29. Klena, J. D., C. A. Schnaitman. 1993. Function of the rfb gene cluster and the rfe gene in the synthesis of O antigen by Shigella dysenteriae 1. Mol. Microbiol. 9: 393-402. [Medline]
  30. Pradel, E., C. A. Schnaitman. 1991. Effect of rfaH (sfrB) and temperature on expression of rfa genes of Escherichia coli K-12. J. Bacteriol. 173: 6428-6431. [Abstract/Free Full Text]
  31. Klena, J. D., E. Pradel, C. A. Schnaitman. 1992. Comparison of lipopolysaccharide biosynthesis genes rfaK, rfaL, rfaY, and rfaZ of Escherichia coli K-12 and Salmonella typhimurium. J. Bacteriol. 174: 4746-4752. [Abstract/Free Full Text]
  32. Pradel, E., C. T. Parker, C. A. Schnaitman. 1992. Structures of the rfaB, rfaI, rfaJ, and rfaS genes of Escherichia coli K-12 and their roles in assembly of the lipopolysaccharide core. J. Bacteriol. 174: 4736-4745. [Abstract/Free Full Text]
  33. Parker, C. T., A. W. Kloser, C. A. Schnaitman, M. A. Stein, S. Gottesman, B. W. Gibson. 1992. Role of the rfaG and rfaP genes in determining the lipopolysaccharide core structure and cell surface properties of Escherichia coli K-12. J. Bacteriol. 174: 2525-2538. [Abstract/Free Full Text]
  34. Parker, C. T., E. Pradel, C. A. Schnaitman. 1992. Identification and sequences of the lipopolysaccharide core biosynthetic genes rfaQ, rfaP, and rfaG of Escherichia coli K-12. J. Bacteriol. 174: 930-934. [Abstract/Free Full Text]
  35. Feng, P., R. C. Sandlin, C. H. Park, R. A. Wilson, M. Nishibuchi. 1998. Identification of a rough strain of Escherichia coli O157:H7 that produces no detectable O157 antigen. J. Clin. Microbiol. 36: 2339-2341. [Abstract/Free Full Text]
  36. Svanborg Eden, C., R. Hull, S. Falkow, H. Leffler. 1983. Target cell specificity of wild-type E. coli and mutants and clones with genetically defined adhesins. Prog. Food Nutr. Sci. 7: 75-89. [Medline]
  37. Sanderson, K. E., J. Van Wyngaarden, O. Luderitz, B. A. Stocker. 1974. Rough mutants of Salmonella typhimurium with defects in the heptose region of the lipopolysaccharide core. Can. J. Microbiol. 20: 1127-1134. [Medline]
  38. Roantree, R. J., T.-T. Kuo, D. G. MacPhee. 1977. The effect of defined lipopolysaccharide core defects upon antibiotic resistances of Salmonella typhimurium. J. Gen. Microbiol. 103: 223-234. [Abstract/Free Full Text]
  39. Sun, S., B. Schilling, L. Tarantino, M. V. Tullius, B. W. Gibson, R. S. Munson, Jr. 2000. Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi. J. Bacteriol. 182: 2292-2298. [Abstract/Free Full Text]
  40. Belland, R. J., T. Chen, J. Swanson, S. H. Fischer. 1992. Human neutrophil response to recombinant neisserial Opa proteins. Mol. Microbiol. 6: 1729-1737. [Medline]
  41. Chen, T., S. Bolland, I. Chen, J. Parker, M. Pantelic, F. Grunert, W. Zimmermann. 2001. The CGM1a (CEACAM3/CD66d) mediated phagocytic pathway of Neisseria gonorrhoeae expressing Opacity (Opa) proteins is also the pathway to cell death. J. Biol. Chem. 276: 17413-17419. [Abstract/Free Full Text]
  42. Chen, T., E. Gotschlich. 1996. CGM1a antigen of neutrophils, a receptor of gonococcal opacity proteins. Proc. Natl. Acad. Sci. USA 93: 14851-14856. [Abstract/Free Full Text]
  43. SolFoulon, N., A. Moris, C. Nobile, C. Boccaccio, A. Engering, J. P. Abastado, J. M. Heard, Y. van Kooyk, O. Schwartz. 2002. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16: 145-155. [Medline]
  44. Nobile, C., A. Moris, F. Porrot, N. Sol-Foulon, O. Schwartz. 2003. Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN. J. Virol. 77: 5313-5323. [Abstract/Free Full Text]
  45. Chen, T., F. Grunert, A. Medina-Marino, E. Gotschlich. 1997. Several carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity proteins. J. Exp. Med. 185: 1557-1564. [Abstract/Free Full Text]
  46. Westphal, O., K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carb. Chem. 5: 83-91.
  47. Rosner, M. R., H. G. Khorana, A. C. Satterthwait. 1979. The structure of lipopolysaccharide from a heptose-less mutant of Escherichia coli K-12. II. The application of 31P NMR spectroscopy. J. Biol. Chem. 254: 5818-5825. [Medline]
  48. Bulgheresi, S., I. Schabussova, T. Chen, N. P. Mullin, R. M. Maizels, J. A. Ott. 2006. A new C-type lectin similar to the human immunoreceptor DC-SIGN mediates symbiont acquisition by a marine nematode. Appl. Environ. Microbiol. 72: 2950-2956. [Abstract/Free Full Text]
  49. Heinrichs, D. E., J. A. Yethon, C. Whitfield. 1998. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol. Microbiol. 30: 221-232. [Medline]
  50. Whitfield, C., N. Kaniuk, E. Frirdich. 2003. Molecular insights into the assembly and diversity of the outer core oligosaccharide in lipopolysaccharides from Escherichia coli and Salmonella. J. Endotoxin Res. 9: 244-249.
  51. Steeghs, L., U. Uronen-hansson, S. Van vliet, A. Van mourik, N. Klein, Y. Van kooyk, R. Callard, J. Van de winkel, P. Van der ley. 2006. Lipopolysaccharide-mediated targeting of Neisseria meningitidis to dendritic cells: binding of lgtB LPS to DC-SIGN. Cell. Microbiol. 8: 316-325. [Medline]
  52. Geijtenbeek, T. B., G. C. van Duijnhoven, S. J. van Vliet, E. Krieger, G. Vriend, C. G. Figdor, Y. van Kooyk. 2002. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J. Biol. Chem. 277: 11314-11320. [Abstract/Free Full Text]
  53. Feinberg, H., D. A. Mitchell, K. Drickamer, W. I. Weis. 2001. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294: 2163-2166. [Abstract/Free Full Text]
  54. Seddiki, N., L. Rabehi, A. Benjouad, L. Saffar, F. Ferriere, J. C. Gluckman, L. Gattegno. 1997. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes. Glycobiology 7: 1229-1236. [Abstract/Free Full Text]
  55. Mandrell, R. E., R. McLaughlin, Y. Aba Kwaik, A. Lesse, R. Yamasaki, B. Gibson, S. M. Spinola, M. A. Apicella. 1992. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Infect. Immun. 60: 1322-1328. [Abstract/Free Full Text]
  56. Mandrell, R. E., M. A. Apicella. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187: 382-402. [Medline]
  57. Edwards, J. L., M. A. Apicella. 2002. The role of lipooligosaccharide in Neisseria gonorrhoeae pathogenesis of cervical epithelia: lipid A serves as a C3 acceptor molecule. Cell. Microbiol. 4: 585-598. [Medline]
  58. Edwards, J. L., E. J. Brown, K. A. Ault, M. A. Apicella. 2001. The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia. Cell. Microbiol. 3: 611-622. [Medline]
  59. Harvey, H. A., N. Porat, C. A. Campbell, M. Jennings, B. W. Gibson, N. J. Phillips, M. A. Apicella, M. S. Blake. 2000. Gonococcal lipooligosaccharide is a ligand for the asialoglycoprotein receptor on human sperm. Mol. Microbiol. 36: 1059-1070. [Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
R. Mittal, S. Bulgheresi, C. Emami, and N. V. Prasadarao
Enterobacter sakazakii Targets DC-SIGN to Induce Immunosuppressive Responses in Dendritic Cells by Modulating MAPKs
J. Immunol., November 15, 2009; 183(10): 6588 - 6599.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. D. Kamda and S. M. Singer
Phosphoinositide 3-Kinase-Dependent Inhibition of Dendritic Cell Interleukin-12 Production by Giardia lamblia
Infect. Immun., February 1, 2009; 77(2): 685 - 693.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S.-s. Zhang, C. G. Park, P. Zhang, S. S. Bartra, G. V. Plano, J. D. Klena, M. Skurnik, B. J. Hinnebusch, and T. Chen
Plasminogen Activator Pla of Yersinia pestis Utilizes Murine DEC-205 (CD205) as a Receptor to Promote Dissemination
J. Biol. Chem., November 14, 2008; 283(46): 31511 - 31521.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. Zhang, M. Skurnik, S.-S. Zhang, O. Schwartz, R. Kalyanasundaram, S. Bulgheresi, J. J. He, J. D. Klena, B. J. Hinnebusch, and T. Chen
Human Dendritic Cell-Specific Intercellular Adhesion Molecule-Grabbing Nonintegrin (CD209) Is a Receptor for Yersinia pestis That Promotes Phagocytosis by Dendritic Cells
Infect. Immun., May 1, 2008; 76(5): 2070 - 2079.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Sahly, Y. Keisari, E. Crouch, N. Sharon, and I. Ofek
Recognition of Bacterial Surface Polysaccharides by Lectins of the Innate Immune System and Its Contribution to Defense against Infection: the Case of Pulmonary Pathogens
Infect. Immun., April 1, 2008; 76(4): 1322 - 1332.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. E. Banks, T. L. Humphreys, W. Li, B. P. Katz, D. S. Wilkes, and S. M. Spinola
Haemophilus ducreyi Partially Activates Human Myeloid Dendritic Cells
Infect. Immun., December 1, 2007; 75(12): 5678 - 5685.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, P.
Right arrow Articles by Chen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, P.
Right arrow Articles by Chen, T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS